Inherited p40phox deficiency differs from classic chronic granulomatous disease

Annemarie van de Geer(Sanquin), Alejandro Nieto-Patlán(Inserm), Douglas B. Kuhns(Leidos (United States)), Anton T. J. Tool(Sanquin), Andrés A. Arias(Universidad de Antioquia), Matthieu Bouaziz(Inserm), Martin de Boer(Sanquin), José Luis Franco, Roel P. Gazendam(Sanquin), John L. van Hamme(Sanquin), Michel van Houdt(Sanquin), Karin van Leeuwen(Sanquin), Paul Verkuijlen(Sanquin), Timo K. van den Berg(Sanquin), Juan F. Álzate(Universidad de Antioquia), Carlos A. Arango-Franco(Universidad de Antioquia), Vritika Batura(University of Toronto), Andrea Bernasconi(Garrahan Hospital), Barbara Boardman(Royal Manchester Children's Hospital), Claire Booth(Great Ormond Street Hospital for Children NHS Foundation Trust), Siobhan O. Burns(Royal Free London NHS Foundation Trust), Felipe Cabarcas(Universidad de Antioquia), Nadine Cerf–Bensussan(Délégation Paris 5), Fabienne Charbit‐Henrion(Délégation Paris 5), Anniek Corveleyn(KU Leuven), Caroline Deswarte(Inserm), María Esnaola Azcoiti(Inserm), Dirk Foell(University Hospital Münster), John I. Gallin(National Institute of Allergy and Infectious Diseases), Carlos Garcés, Margarida Guedes(Hospital de Santo António), Claas Hinze(University Hospital Münster), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Stephen Hughes(Royal Manchester Children's Hospital), Patricio Ibáñez(Clínica Las Condes), Harry L. Malech(National Institute of Allergy and Infectious Diseases), Isabelle Meyts(KU Leuven), Marcela Moncada‐Vélez, Kunihiko Moriya(Inserm), Esmeralda Neves(Hospital de Santo António), Matías Oleastro(Garrahan Hospital), Laura Pérez(Garrahan Hospital), Vimel Rattina(Inserm), Carmen Oleaga‐Quintas(Inserm), Neil Warner(SickKids Foundation), Aleixo M. Muise(University of Toronto), Jeanet Serafín‐López(Tecnológico Nacional de México), Eunice Trindade(Hospital de São João), Julia Vasconcelos(Hospital de Santo António), Séverine Vermeire(KU Leuven), Helmut Wittkowski(University Hospital Münster), Austen Worth(Great Ormond Street Hospital for Children NHS Foundation Trust), Laurent Abel(Inserm), Mary C. Dinauer(Washington University in St. Louis), Peter D. Arkwright(Royal Manchester Children's Hospital), Dirk Roos(Sanquin), Jean‐Laurent Casanova(Howard Hughes Medical Institute), Taco W. Kuijpers(Amsterdam UMC Location University of Amsterdam), Jacinta Bustamante(Inserm)
Journal of Clinical Investigation
July 3, 2018
Cited by 132Open Access
Full Text

Abstract

Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40phox subunit of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 p40phox-deficient patients from 12 additional families in 8 countries. These patients display 8 different in-frame or out-of-frame mutations of NCF4 that are homozygous in 11 of the families and compound heterozygous in another. When overexpressed in NB4 neutrophil-like cells and EBV-transformed B cells in vitro, the mutant alleles were found to be LOF, with the exception of the p.R58C and c.120_134del alleles, which were hypomorphic. Particle-induced NADPH oxidase activity was severely impaired in the patients' neutrophils, whereas PMA-induced dihydrorhodamine-1,2,3 (DHR) oxidation, which is widely used as a diagnostic test for chronic granulomatous disease (CGD), was normal or mildly impaired in the patients. Moreover, the NADPH oxidase activity of EBV-transformed B cells was also severely impaired, whereas that of mononuclear phagocytes was normal. Finally, the killing of Candida albicans and Aspergillus fumigatus hyphae by neutrophils was conserved in these patients, unlike in patients with CGD. The patients suffer from hyperinflammation and peripheral infections, but they do not have any of the invasive bacterial or fungal infections seen in CGD. Inherited p40phox deficiency underlies a distinctive condition, resembling a mild, atypical form of CGD.


Related Papers

No related papers found

Powered by citation graph analysis